Global Intravitreal Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Intravitreal Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Intravitreal injection is a drug that is injected directly into the vitreous cavity of the eye and is mainly used to treat various fundus diseases.
The Global Info Research report includes an overview of the development of the Intravitreal Injection industry chain, the market status of Diabetic Eye Disease (Ranibizumab, Bevacizumab), AMD (Ranibizumab, Bevacizumab), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Intravitreal Injection.
Regionally, the report analyzes the Intravitreal Injection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Intravitreal Injection market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Intravitreal Injection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Intravitreal Injection industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Ranibizumab, Bevacizumab).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Intravitreal Injection market.
Regional Analysis: The report involves examining the Intravitreal Injection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Intravitreal Injection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Intravitreal Injection:
Company Analysis: Report covers individual Intravitreal Injection manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Intravitreal Injection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Diabetic Eye Disease, AMD).
Technology Analysis: Report covers specific technologies relevant to Intravitreal Injection. It assesses the current state, advancements, and potential future developments in Intravitreal Injection areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Intravitreal Injection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Intravitreal Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Intravitreal Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intravitreal Injection, with price, sales, revenue and global market share of Intravitreal Injection from 2019 to 2024.
Chapter 3, the Intravitreal Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravitreal Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Intravitreal Injection market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intravitreal Injection.
Chapter 14 and 15, to describe Intravitreal Injection sales channel, distributors, customers, research findings and conclusion.
Intravitreal injection is a drug that is injected directly into the vitreous cavity of the eye and is mainly used to treat various fundus diseases.
The Global Info Research report includes an overview of the development of the Intravitreal Injection industry chain, the market status of Diabetic Eye Disease (Ranibizumab, Bevacizumab), AMD (Ranibizumab, Bevacizumab), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Intravitreal Injection.
Regionally, the report analyzes the Intravitreal Injection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Intravitreal Injection market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Intravitreal Injection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Intravitreal Injection industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Ranibizumab, Bevacizumab).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Intravitreal Injection market.
Regional Analysis: The report involves examining the Intravitreal Injection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Intravitreal Injection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Intravitreal Injection:
Company Analysis: Report covers individual Intravitreal Injection manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Intravitreal Injection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Diabetic Eye Disease, AMD).
Technology Analysis: Report covers specific technologies relevant to Intravitreal Injection. It assesses the current state, advancements, and potential future developments in Intravitreal Injection areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Intravitreal Injection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Intravitreal Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Ranibizumab
- Bevacizumab
- Aflibercept
- Brolucizumab
- Faricimab
- Others
- Diabetic Eye Disease
- AMD
- Retinal Vein Occlusion
- Others
- Sanofi
- Novartis
- Bayer
- Genentech
- Apellis Pharmaceuticals, Inc.
- Coherus BioSciences Inc.
- Iveric Bio
- Regeneron
- Roche
- Qilu Pharmaceutical Co.,Ltd.
- Chengdu Kanghong Pharmaceutical Group
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Intravitreal Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intravitreal Injection, with price, sales, revenue and global market share of Intravitreal Injection from 2019 to 2024.
Chapter 3, the Intravitreal Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravitreal Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Intravitreal Injection market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intravitreal Injection.
Chapter 14 and 15, to describe Intravitreal Injection sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Intravitreal Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Intravitreal Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Ranibizumab
1.3.3 Bevacizumab
1.3.4 Aflibercept
1.3.5 Brolucizumab
1.3.6 Faricimab
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Intravitreal Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Diabetic Eye Disease
1.4.3 AMD
1.4.4 Retinal Vein Occlusion
1.4.5 Others
1.5 Global Intravitreal Injection Market Size & Forecast
1.5.1 Global Intravitreal Injection Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Intravitreal Injection Sales Quantity (2019-2030)
1.5.3 Global Intravitreal Injection Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Intravitreal Injection Product and Services
2.1.4 Sanofi Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Intravitreal Injection Product and Services
2.2.4 Novartis Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Intravitreal Injection Product and Services
2.3.4 Bayer Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bayer Recent Developments/Updates
2.4 Genentech
2.4.1 Genentech Details
2.4.2 Genentech Major Business
2.4.3 Genentech Intravitreal Injection Product and Services
2.4.4 Genentech Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Genentech Recent Developments/Updates
2.5 Apellis Pharmaceuticals, Inc.
2.5.1 Apellis Pharmaceuticals, Inc. Details
2.5.2 Apellis Pharmaceuticals, Inc. Major Business
2.5.3 Apellis Pharmaceuticals, Inc. Intravitreal Injection Product and Services
2.5.4 Apellis Pharmaceuticals, Inc. Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates
2.6 Coherus BioSciences Inc.
2.6.1 Coherus BioSciences Inc. Details
2.6.2 Coherus BioSciences Inc. Major Business
2.6.3 Coherus BioSciences Inc. Intravitreal Injection Product and Services
2.6.4 Coherus BioSciences Inc. Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Coherus BioSciences Inc. Recent Developments/Updates
2.7 Iveric Bio
2.7.1 Iveric Bio
Details
2.7.2 Iveric Bio
Major Business
2.7.3 Iveric Bio
Intravitreal Injection Product and Services
2.7.4 Iveric Bio
Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Iveric Bio
Recent Developments/Updates
2.8 Regeneron
2.8.1 Regeneron Details
2.8.2 Regeneron Major Business
2.8.3 Regeneron Intravitreal Injection Product and Services
2.8.4 Regeneron Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Regeneron Recent Developments/Updates
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business
2.9.3 Roche Intravitreal Injection Product and Services
2.9.4 Roche Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Roche Recent Developments/Updates
2.10 Qilu Pharmaceutical Co.,Ltd.
2.10.1 Qilu Pharmaceutical Co.,Ltd. Details
2.10.2 Qilu Pharmaceutical Co.,Ltd. Major Business
2.10.3 Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Product and Services
2.10.4 Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
2.11 Chengdu Kanghong Pharmaceutical Group
2.11.1 Chengdu Kanghong Pharmaceutical Group Details
2.11.2 Chengdu Kanghong Pharmaceutical Group Major Business
2.11.3 Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Product and Services
2.11.4 Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INTRAVITREAL INJECTION BY MANUFACTURER
3.1 Global Intravitreal Injection Sales Quantity by Manufacturer (2019-2024)
3.2 Global Intravitreal Injection Revenue by Manufacturer (2019-2024)
3.3 Global Intravitreal Injection Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Intravitreal Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Intravitreal Injection Manufacturer Market Share in 2023
3.4.2 Top 6 Intravitreal Injection Manufacturer Market Share in 2023
3.5 Intravitreal Injection Market: Overall Company Footprint Analysis
3.5.1 Intravitreal Injection Market: Region Footprint
3.5.2 Intravitreal Injection Market: Company Product Type Footprint
3.5.3 Intravitreal Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Intravitreal Injection Market Size by Region
4.1.1 Global Intravitreal Injection Sales Quantity by Region (2019-2030)
4.1.2 Global Intravitreal Injection Consumption Value by Region (2019-2030)
4.1.3 Global Intravitreal Injection Average Price by Region (2019-2030)
4.2 North America Intravitreal Injection Consumption Value (2019-2030)
4.3 Europe Intravitreal Injection Consumption Value (2019-2030)
4.4 Asia-Pacific Intravitreal Injection Consumption Value (2019-2030)
4.5 South America Intravitreal Injection Consumption Value (2019-2030)
4.6 Middle East and Africa Intravitreal Injection Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Intravitreal Injection Sales Quantity by Type (2019-2030)
5.2 Global Intravitreal Injection Consumption Value by Type (2019-2030)
5.3 Global Intravitreal Injection Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Intravitreal Injection Sales Quantity by Application (2019-2030)
6.2 Global Intravitreal Injection Consumption Value by Application (2019-2030)
6.3 Global Intravitreal Injection Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Intravitreal Injection Sales Quantity by Type (2019-2030)
7.2 North America Intravitreal Injection Sales Quantity by Application (2019-2030)
7.3 North America Intravitreal Injection Market Size by Country
7.3.1 North America Intravitreal Injection Sales Quantity by Country (2019-2030)
7.3.2 North America Intravitreal Injection Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Intravitreal Injection Sales Quantity by Type (2019-2030)
8.2 Europe Intravitreal Injection Sales Quantity by Application (2019-2030)
8.3 Europe Intravitreal Injection Market Size by Country
8.3.1 Europe Intravitreal Injection Sales Quantity by Country (2019-2030)
8.3.2 Europe Intravitreal Injection Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Intravitreal Injection Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Intravitreal Injection Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Intravitreal Injection Market Size by Region
9.3.1 Asia-Pacific Intravitreal Injection Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Intravitreal Injection Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Intravitreal Injection Sales Quantity by Type (2019-2030)
10.2 South America Intravitreal Injection Sales Quantity by Application (2019-2030)
10.3 South America Intravitreal Injection Market Size by Country
10.3.1 South America Intravitreal Injection Sales Quantity by Country (2019-2030)
10.3.2 South America Intravitreal Injection Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Intravitreal Injection Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Intravitreal Injection Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Intravitreal Injection Market Size by Country
11.3.1 Middle East & Africa Intravitreal Injection Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Intravitreal Injection Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Intravitreal Injection Market Drivers
12.2 Intravitreal Injection Market Restraints
12.3 Intravitreal Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Intravitreal Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Intravitreal Injection
13.3 Intravitreal Injection Production Process
13.4 Intravitreal Injection Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Intravitreal Injection Typical Distributors
14.3 Intravitreal Injection Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Intravitreal Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Intravitreal Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Ranibizumab
1.3.3 Bevacizumab
1.3.4 Aflibercept
1.3.5 Brolucizumab
1.3.6 Faricimab
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Intravitreal Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Diabetic Eye Disease
1.4.3 AMD
1.4.4 Retinal Vein Occlusion
1.4.5 Others
1.5 Global Intravitreal Injection Market Size & Forecast
1.5.1 Global Intravitreal Injection Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Intravitreal Injection Sales Quantity (2019-2030)
1.5.3 Global Intravitreal Injection Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Intravitreal Injection Product and Services
2.1.4 Sanofi Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Intravitreal Injection Product and Services
2.2.4 Novartis Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Intravitreal Injection Product and Services
2.3.4 Bayer Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bayer Recent Developments/Updates
2.4 Genentech
2.4.1 Genentech Details
2.4.2 Genentech Major Business
2.4.3 Genentech Intravitreal Injection Product and Services
2.4.4 Genentech Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Genentech Recent Developments/Updates
2.5 Apellis Pharmaceuticals, Inc.
2.5.1 Apellis Pharmaceuticals, Inc. Details
2.5.2 Apellis Pharmaceuticals, Inc. Major Business
2.5.3 Apellis Pharmaceuticals, Inc. Intravitreal Injection Product and Services
2.5.4 Apellis Pharmaceuticals, Inc. Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates
2.6 Coherus BioSciences Inc.
2.6.1 Coherus BioSciences Inc. Details
2.6.2 Coherus BioSciences Inc. Major Business
2.6.3 Coherus BioSciences Inc. Intravitreal Injection Product and Services
2.6.4 Coherus BioSciences Inc. Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Coherus BioSciences Inc. Recent Developments/Updates
2.7 Iveric Bio
2.7.1 Iveric Bio
Details
2.7.2 Iveric Bio
Major Business
2.7.3 Iveric Bio
Intravitreal Injection Product and Services
2.7.4 Iveric Bio
Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Iveric Bio
Recent Developments/Updates
2.8 Regeneron
2.8.1 Regeneron Details
2.8.2 Regeneron Major Business
2.8.3 Regeneron Intravitreal Injection Product and Services
2.8.4 Regeneron Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Regeneron Recent Developments/Updates
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business
2.9.3 Roche Intravitreal Injection Product and Services
2.9.4 Roche Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Roche Recent Developments/Updates
2.10 Qilu Pharmaceutical Co.,Ltd.
2.10.1 Qilu Pharmaceutical Co.,Ltd. Details
2.10.2 Qilu Pharmaceutical Co.,Ltd. Major Business
2.10.3 Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Product and Services
2.10.4 Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
2.11 Chengdu Kanghong Pharmaceutical Group
2.11.1 Chengdu Kanghong Pharmaceutical Group Details
2.11.2 Chengdu Kanghong Pharmaceutical Group Major Business
2.11.3 Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Product and Services
2.11.4 Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INTRAVITREAL INJECTION BY MANUFACTURER
3.1 Global Intravitreal Injection Sales Quantity by Manufacturer (2019-2024)
3.2 Global Intravitreal Injection Revenue by Manufacturer (2019-2024)
3.3 Global Intravitreal Injection Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Intravitreal Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Intravitreal Injection Manufacturer Market Share in 2023
3.4.2 Top 6 Intravitreal Injection Manufacturer Market Share in 2023
3.5 Intravitreal Injection Market: Overall Company Footprint Analysis
3.5.1 Intravitreal Injection Market: Region Footprint
3.5.2 Intravitreal Injection Market: Company Product Type Footprint
3.5.3 Intravitreal Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Intravitreal Injection Market Size by Region
4.1.1 Global Intravitreal Injection Sales Quantity by Region (2019-2030)
4.1.2 Global Intravitreal Injection Consumption Value by Region (2019-2030)
4.1.3 Global Intravitreal Injection Average Price by Region (2019-2030)
4.2 North America Intravitreal Injection Consumption Value (2019-2030)
4.3 Europe Intravitreal Injection Consumption Value (2019-2030)
4.4 Asia-Pacific Intravitreal Injection Consumption Value (2019-2030)
4.5 South America Intravitreal Injection Consumption Value (2019-2030)
4.6 Middle East and Africa Intravitreal Injection Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Intravitreal Injection Sales Quantity by Type (2019-2030)
5.2 Global Intravitreal Injection Consumption Value by Type (2019-2030)
5.3 Global Intravitreal Injection Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Intravitreal Injection Sales Quantity by Application (2019-2030)
6.2 Global Intravitreal Injection Consumption Value by Application (2019-2030)
6.3 Global Intravitreal Injection Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Intravitreal Injection Sales Quantity by Type (2019-2030)
7.2 North America Intravitreal Injection Sales Quantity by Application (2019-2030)
7.3 North America Intravitreal Injection Market Size by Country
7.3.1 North America Intravitreal Injection Sales Quantity by Country (2019-2030)
7.3.2 North America Intravitreal Injection Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Intravitreal Injection Sales Quantity by Type (2019-2030)
8.2 Europe Intravitreal Injection Sales Quantity by Application (2019-2030)
8.3 Europe Intravitreal Injection Market Size by Country
8.3.1 Europe Intravitreal Injection Sales Quantity by Country (2019-2030)
8.3.2 Europe Intravitreal Injection Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Intravitreal Injection Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Intravitreal Injection Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Intravitreal Injection Market Size by Region
9.3.1 Asia-Pacific Intravitreal Injection Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Intravitreal Injection Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Intravitreal Injection Sales Quantity by Type (2019-2030)
10.2 South America Intravitreal Injection Sales Quantity by Application (2019-2030)
10.3 South America Intravitreal Injection Market Size by Country
10.3.1 South America Intravitreal Injection Sales Quantity by Country (2019-2030)
10.3.2 South America Intravitreal Injection Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Intravitreal Injection Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Intravitreal Injection Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Intravitreal Injection Market Size by Country
11.3.1 Middle East & Africa Intravitreal Injection Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Intravitreal Injection Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Intravitreal Injection Market Drivers
12.2 Intravitreal Injection Market Restraints
12.3 Intravitreal Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Intravitreal Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Intravitreal Injection
13.3 Intravitreal Injection Production Process
13.4 Intravitreal Injection Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Intravitreal Injection Typical Distributors
14.3 Intravitreal Injection Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Intravitreal Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Intravitreal Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Intravitreal Injection Product and Services
Table 6. Sanofi Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Recent Developments/Updates
Table 8. Novartis Basic Information, Manufacturing Base and Competitors
Table 9. Novartis Major Business
Table 10. Novartis Intravitreal Injection Product and Services
Table 11. Novartis Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Novartis Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Intravitreal Injection Product and Services
Table 16. Bayer Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bayer Recent Developments/Updates
Table 18. Genentech Basic Information, Manufacturing Base and Competitors
Table 19. Genentech Major Business
Table 20. Genentech Intravitreal Injection Product and Services
Table 21. Genentech Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Genentech Recent Developments/Updates
Table 23. Apellis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Apellis Pharmaceuticals, Inc. Major Business
Table 25. Apellis Pharmaceuticals, Inc. Intravitreal Injection Product and Services
Table 26. Apellis Pharmaceuticals, Inc. Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Apellis Pharmaceuticals, Inc. Recent Developments/Updates
Table 28. Coherus BioSciences Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Coherus BioSciences Inc. Major Business
Table 30. Coherus BioSciences Inc. Intravitreal Injection Product and Services
Table 31. Coherus BioSciences Inc. Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Coherus BioSciences Inc. Recent Developments/Updates
Table 33. Iveric Bio
Basic Information, Manufacturing Base and Competitors
Table 34. Iveric Bio
Major Business
Table 35. Iveric Bio
Intravitreal Injection Product and Services
Table 36. Iveric Bio
Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Iveric Bio
Recent Developments/Updates
Table 38. Regeneron Basic Information, Manufacturing Base and Competitors
Table 39. Regeneron Major Business
Table 40. Regeneron Intravitreal Injection Product and Services
Table 41. Regeneron Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Regeneron Recent Developments/Updates
Table 43. Roche Basic Information, Manufacturing Base and Competitors
Table 44. Roche Major Business
Table 45. Roche Intravitreal Injection Product and Services
Table 46. Roche Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Roche Recent Developments/Updates
Table 48. Qilu Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Qilu Pharmaceutical Co.,Ltd. Major Business
Table 50. Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Product and Services
Table 51. Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 53. Chengdu Kanghong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 54. Chengdu Kanghong Pharmaceutical Group Major Business
Table 55. Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Product and Services
Table 56. Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
Table 58. Global Intravitreal Injection Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 59. Global Intravitreal Injection Revenue by Manufacturer (2019-2024) & (USD Million)
Table 60. Global Intravitreal Injection Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 61. Market Position of Manufacturers in Intravitreal Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 62. Head Office and Intravitreal Injection Production Site of Key Manufacturer
Table 63. Intravitreal Injection Market: Company Product Type Footprint
Table 64. Intravitreal Injection Market: Company Product Application Footprint
Table 65. Intravitreal Injection New Market Entrants and Barriers to Market Entry
Table 66. Intravitreal Injection Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Intravitreal Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 68. Global Intravitreal Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 69. Global Intravitreal Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 70. Global Intravitreal Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 71. Global Intravitreal Injection Average Price by Region (2019-2024) & (US$/Unit)
Table 72. Global Intravitreal Injection Average Price by Region (2025-2030) & (US$/Unit)
Table 73. Global Intravitreal Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 74. Global Intravitreal Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 75. Global Intravitreal Injection Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Global Intravitreal Injection Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Global Intravitreal Injection Average Price by Type (2019-2024) & (US$/Unit)
Table 78. Global Intravitreal Injection Average Price by Type (2025-2030) & (US$/Unit)
Table 79. Global Intravitreal Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 80. Global Intravitreal Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 81. Global Intravitreal Injection Consumption Value by Application (2019-2024) & (USD Million)
Table 82. Global Intravitreal Injection Consumption Value by Application (2025-2030) & (USD Million)
Table 83. Global Intravitreal Injection Average Price by Application (2019-2024) & (US$/Unit)
Table 84. Global Intravitreal Injection Average Price by Application (2025-2030) & (US$/Unit)
Table 85. North America Intravitreal Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 86. North America Intravitreal Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 87. North America Intravitreal Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 88. North America Intravitreal Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 89. North America Intravitreal Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 90. North America Intravitreal Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 91. North America Intravitreal Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 92. North America Intravitreal Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Europe Intravitreal Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 94. Europe Intravitreal Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 95. Europe Intravitreal Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 96. Europe Intravitreal Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 97. Europe Intravitreal Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 98. Europe Intravitreal Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 99. Europe Intravitreal Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Intravitreal Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Intravitreal Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 102. Asia-Pacific Intravitreal Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 103. Asia-Pacific Intravitreal Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 104. Asia-Pacific Intravitreal Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 105. Asia-Pacific Intravitreal Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 106. Asia-Pacific Intravitreal Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 107. Asia-Pacific Intravitreal Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 108. Asia-Pacific Intravitreal Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 109. South America Intravitreal Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 110. South America Intravitreal Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 111. South America Intravitreal Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 112. South America Intravitreal Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 113. South America Intravitreal Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 114. South America Intravitreal Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 115. South America Intravitreal Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 116. South America Intravitreal Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 117. Middle East & Africa Intravitreal Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 118. Middle East & Africa Intravitreal Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 119. Middle East & Africa Intravitreal Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 120. Middle East & Africa Intravitreal Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 121. Middle East & Africa Intravitreal Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 122. Middle East & Africa Intravitreal Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 123. Middle East & Africa Intravitreal Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 124. Middle East & Africa Intravitreal Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 125. Intravitreal Injection Raw Material
Table 126. Key Manufacturers of Intravitreal Injection Raw Materials
Table 127. Intravitreal Injection Typical Distributors
Table 128. Intravitreal Injection Typical Customers
LIST OF FIGURE
s
Figure 1. Intravitreal Injection Picture
Figure 2. Global Intravitreal Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Intravitreal Injection Consumption Value Market Share by Type in 2023
Figure 4. Ranibizumab Examples
Figure 5. Bevacizumab Examples
Figure 6. Aflibercept Examples
Figure 7. Brolucizumab Examples
Figure 8. Faricimab Examples
Figure 9. Others Examples
Figure 10. Global Intravitreal Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Intravitreal Injection Consumption Value Market Share by Application in 2023
Figure 12. Diabetic Eye Disease Examples
Figure 13. AMD Examples
Figure 14. Retinal Vein Occlusion Examples
Figure 15. Others Examples
Figure 16. Global Intravitreal Injection Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Intravitreal Injection Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Intravitreal Injection Sales Quantity (2019-2030) & (K Units)
Figure 19. Global Intravitreal Injection Average Price (2019-2030) & (US$/Unit)
Figure 20. Global Intravitreal Injection Sales Quantity Market Share by Manufacturer in 2023
Figure 21. Global Intravitreal Injection Consumption Value Market Share by Manufacturer in 2023
Figure 22. Producer Shipments of Intravitreal Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 23. Top 3 Intravitreal Injection Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Top 6 Intravitreal Injection Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Global Intravitreal Injection Sales Quantity Market Share by Region (2019-2030)
Figure 26. Global Intravitreal Injection Consumption Value Market Share by Region (2019-2030)
Figure 27. North America Intravitreal Injection Consumption Value (2019-2030) & (USD Million)
Figure 28. Europe Intravitreal Injection Consumption Value (2019-2030) & (USD Million)
Figure 29. Asia-Pacific Intravitreal Injection Consumption Value (2019-2030) & (USD Million)
Figure 30. South America Intravitreal Injection Consumption Value (2019-2030) & (USD Million)
Figure 31. Middle East & Africa Intravitreal Injection Consumption Value (2019-2030) & (USD Million)
Figure 32. Global Intravitreal Injection Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Intravitreal Injection Consumption Value Market Share by Type (2019-2030)
Figure 34. Global Intravitreal Injection Average Price by Type (2019-2030) & (US$/Unit)
Figure 35. Global Intravitreal Injection Sales Quantity Market Share by Application (2019-2030)
Figure 36. Global Intravitreal Injection Consumption Value Market Share by Application (2019-2030)
Figure 37. Global Intravitreal Injection Average Price by Application (2019-2030) & (US$/Unit)
Figure 38. North America Intravitreal Injection Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Intravitreal Injection Sales Quantity Market Share by Application (2019-2030)
Figure 40. North America Intravitreal Injection Sales Quantity Market Share by Country (2019-2030)
Figure 41. North America Intravitreal Injection Consumption Value Market Share by Country (2019-2030)
Figure 42. United States Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Canada Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Mexico Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Europe Intravitreal Injection Sales Quantity Market Share by Type (2019-2030)
Figure 46. Europe Intravitreal Injection Sales Quantity Market Share by Application (2019-2030)
Figure 47. Europe Intravitreal Injection Sales Quantity Market Share by Country (2019-2030)
Figure 48. Europe Intravitreal Injection Consumption Value Market Share by Country (2019-2030)
Figure 49. Germany Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. France Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. United Kingdom Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Russia Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Italy Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Asia-Pacific Intravitreal Injection Sales Quantity Market Share by Type (2019-2030)
Figure 55. Asia-Pacific Intravitreal Injection Sales Quantity Market Share by Application (2019-2030)
Figure 56. Asia-Pacific Intravitreal Injection Sales Quantity Market Share by Region (2019-2030)
Figure 57. Asia-Pacific Intravitreal Injection Consumption Value Market Share by Region (2019-2030)
Figure 58. China Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Japan Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Korea Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. India Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Southeast Asia Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Australia Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. South America Intravitreal Injection Sales Quantity Market Share by Type (2019-2030)
Figure 65. South America Intravitreal Injection Sales Quantity Market Share by Application (2019-2030)
Figure 66. South America Intravitreal Injection Sales Quantity Market Share by Country (2019-2030)
Figure 67. South America Intravitreal Injection Consumption Value Market Share by Country (2019-2030)
Figure 68. Brazil Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Argentina Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Middle East & Africa Intravitreal Injection Sales Quantity Market Share by Type (2019-2030)
Figure 71. Middle East & Africa Intravitreal Injection Sales Quantity Market Share by Application (2019-2030)
Figure 72. Middle East & Africa Intravitreal Injection Sales Quantity Market Share by Region (2019-2030)
Figure 73. Middle East & Africa Intravitreal Injection Consumption Value Market Share by Region (2019-2030)
Figure 74. Turkey Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Egypt Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Saudi Arabia Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. South Africa Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Intravitreal Injection Market Drivers
Figure 79. Intravitreal Injection Market Restraints
Figure 80. Intravitreal Injection Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Intravitreal Injection in 2023
Figure 83. Manufacturing Process Analysis of Intravitreal Injection
Figure 84. Intravitreal Injection Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
Table 1. Global Intravitreal Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Intravitreal Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Intravitreal Injection Product and Services
Table 6. Sanofi Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Recent Developments/Updates
Table 8. Novartis Basic Information, Manufacturing Base and Competitors
Table 9. Novartis Major Business
Table 10. Novartis Intravitreal Injection Product and Services
Table 11. Novartis Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Novartis Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Intravitreal Injection Product and Services
Table 16. Bayer Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bayer Recent Developments/Updates
Table 18. Genentech Basic Information, Manufacturing Base and Competitors
Table 19. Genentech Major Business
Table 20. Genentech Intravitreal Injection Product and Services
Table 21. Genentech Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Genentech Recent Developments/Updates
Table 23. Apellis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Apellis Pharmaceuticals, Inc. Major Business
Table 25. Apellis Pharmaceuticals, Inc. Intravitreal Injection Product and Services
Table 26. Apellis Pharmaceuticals, Inc. Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Apellis Pharmaceuticals, Inc. Recent Developments/Updates
Table 28. Coherus BioSciences Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Coherus BioSciences Inc. Major Business
Table 30. Coherus BioSciences Inc. Intravitreal Injection Product and Services
Table 31. Coherus BioSciences Inc. Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Coherus BioSciences Inc. Recent Developments/Updates
Table 33. Iveric Bio
Basic Information, Manufacturing Base and Competitors
Table 34. Iveric Bio
Major Business
Table 35. Iveric Bio
Intravitreal Injection Product and Services
Table 36. Iveric Bio
Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Iveric Bio
Recent Developments/Updates
Table 38. Regeneron Basic Information, Manufacturing Base and Competitors
Table 39. Regeneron Major Business
Table 40. Regeneron Intravitreal Injection Product and Services
Table 41. Regeneron Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Regeneron Recent Developments/Updates
Table 43. Roche Basic Information, Manufacturing Base and Competitors
Table 44. Roche Major Business
Table 45. Roche Intravitreal Injection Product and Services
Table 46. Roche Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Roche Recent Developments/Updates
Table 48. Qilu Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Qilu Pharmaceutical Co.,Ltd. Major Business
Table 50. Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Product and Services
Table 51. Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 53. Chengdu Kanghong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 54. Chengdu Kanghong Pharmaceutical Group Major Business
Table 55. Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Product and Services
Table 56. Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
Table 58. Global Intravitreal Injection Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 59. Global Intravitreal Injection Revenue by Manufacturer (2019-2024) & (USD Million)
Table 60. Global Intravitreal Injection Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 61. Market Position of Manufacturers in Intravitreal Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 62. Head Office and Intravitreal Injection Production Site of Key Manufacturer
Table 63. Intravitreal Injection Market: Company Product Type Footprint
Table 64. Intravitreal Injection Market: Company Product Application Footprint
Table 65. Intravitreal Injection New Market Entrants and Barriers to Market Entry
Table 66. Intravitreal Injection Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Intravitreal Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 68. Global Intravitreal Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 69. Global Intravitreal Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 70. Global Intravitreal Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 71. Global Intravitreal Injection Average Price by Region (2019-2024) & (US$/Unit)
Table 72. Global Intravitreal Injection Average Price by Region (2025-2030) & (US$/Unit)
Table 73. Global Intravitreal Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 74. Global Intravitreal Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 75. Global Intravitreal Injection Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Global Intravitreal Injection Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Global Intravitreal Injection Average Price by Type (2019-2024) & (US$/Unit)
Table 78. Global Intravitreal Injection Average Price by Type (2025-2030) & (US$/Unit)
Table 79. Global Intravitreal Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 80. Global Intravitreal Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 81. Global Intravitreal Injection Consumption Value by Application (2019-2024) & (USD Million)
Table 82. Global Intravitreal Injection Consumption Value by Application (2025-2030) & (USD Million)
Table 83. Global Intravitreal Injection Average Price by Application (2019-2024) & (US$/Unit)
Table 84. Global Intravitreal Injection Average Price by Application (2025-2030) & (US$/Unit)
Table 85. North America Intravitreal Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 86. North America Intravitreal Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 87. North America Intravitreal Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 88. North America Intravitreal Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 89. North America Intravitreal Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 90. North America Intravitreal Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 91. North America Intravitreal Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 92. North America Intravitreal Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Europe Intravitreal Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 94. Europe Intravitreal Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 95. Europe Intravitreal Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 96. Europe Intravitreal Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 97. Europe Intravitreal Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 98. Europe Intravitreal Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 99. Europe Intravitreal Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Intravitreal Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Intravitreal Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 102. Asia-Pacific Intravitreal Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 103. Asia-Pacific Intravitreal Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 104. Asia-Pacific Intravitreal Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 105. Asia-Pacific Intravitreal Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 106. Asia-Pacific Intravitreal Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 107. Asia-Pacific Intravitreal Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 108. Asia-Pacific Intravitreal Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 109. South America Intravitreal Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 110. South America Intravitreal Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 111. South America Intravitreal Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 112. South America Intravitreal Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 113. South America Intravitreal Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 114. South America Intravitreal Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 115. South America Intravitreal Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 116. South America Intravitreal Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 117. Middle East & Africa Intravitreal Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 118. Middle East & Africa Intravitreal Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 119. Middle East & Africa Intravitreal Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 120. Middle East & Africa Intravitreal Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 121. Middle East & Africa Intravitreal Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 122. Middle East & Africa Intravitreal Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 123. Middle East & Africa Intravitreal Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 124. Middle East & Africa Intravitreal Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 125. Intravitreal Injection Raw Material
Table 126. Key Manufacturers of Intravitreal Injection Raw Materials
Table 127. Intravitreal Injection Typical Distributors
Table 128. Intravitreal Injection Typical Customers
LIST OF FIGURE
s
Figure 1. Intravitreal Injection Picture
Figure 2. Global Intravitreal Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Intravitreal Injection Consumption Value Market Share by Type in 2023
Figure 4. Ranibizumab Examples
Figure 5. Bevacizumab Examples
Figure 6. Aflibercept Examples
Figure 7. Brolucizumab Examples
Figure 8. Faricimab Examples
Figure 9. Others Examples
Figure 10. Global Intravitreal Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Intravitreal Injection Consumption Value Market Share by Application in 2023
Figure 12. Diabetic Eye Disease Examples
Figure 13. AMD Examples
Figure 14. Retinal Vein Occlusion Examples
Figure 15. Others Examples
Figure 16. Global Intravitreal Injection Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Intravitreal Injection Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Intravitreal Injection Sales Quantity (2019-2030) & (K Units)
Figure 19. Global Intravitreal Injection Average Price (2019-2030) & (US$/Unit)
Figure 20. Global Intravitreal Injection Sales Quantity Market Share by Manufacturer in 2023
Figure 21. Global Intravitreal Injection Consumption Value Market Share by Manufacturer in 2023
Figure 22. Producer Shipments of Intravitreal Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 23. Top 3 Intravitreal Injection Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Top 6 Intravitreal Injection Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Global Intravitreal Injection Sales Quantity Market Share by Region (2019-2030)
Figure 26. Global Intravitreal Injection Consumption Value Market Share by Region (2019-2030)
Figure 27. North America Intravitreal Injection Consumption Value (2019-2030) & (USD Million)
Figure 28. Europe Intravitreal Injection Consumption Value (2019-2030) & (USD Million)
Figure 29. Asia-Pacific Intravitreal Injection Consumption Value (2019-2030) & (USD Million)
Figure 30. South America Intravitreal Injection Consumption Value (2019-2030) & (USD Million)
Figure 31. Middle East & Africa Intravitreal Injection Consumption Value (2019-2030) & (USD Million)
Figure 32. Global Intravitreal Injection Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Intravitreal Injection Consumption Value Market Share by Type (2019-2030)
Figure 34. Global Intravitreal Injection Average Price by Type (2019-2030) & (US$/Unit)
Figure 35. Global Intravitreal Injection Sales Quantity Market Share by Application (2019-2030)
Figure 36. Global Intravitreal Injection Consumption Value Market Share by Application (2019-2030)
Figure 37. Global Intravitreal Injection Average Price by Application (2019-2030) & (US$/Unit)
Figure 38. North America Intravitreal Injection Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Intravitreal Injection Sales Quantity Market Share by Application (2019-2030)
Figure 40. North America Intravitreal Injection Sales Quantity Market Share by Country (2019-2030)
Figure 41. North America Intravitreal Injection Consumption Value Market Share by Country (2019-2030)
Figure 42. United States Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Canada Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Mexico Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Europe Intravitreal Injection Sales Quantity Market Share by Type (2019-2030)
Figure 46. Europe Intravitreal Injection Sales Quantity Market Share by Application (2019-2030)
Figure 47. Europe Intravitreal Injection Sales Quantity Market Share by Country (2019-2030)
Figure 48. Europe Intravitreal Injection Consumption Value Market Share by Country (2019-2030)
Figure 49. Germany Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. France Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. United Kingdom Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Russia Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Italy Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Asia-Pacific Intravitreal Injection Sales Quantity Market Share by Type (2019-2030)
Figure 55. Asia-Pacific Intravitreal Injection Sales Quantity Market Share by Application (2019-2030)
Figure 56. Asia-Pacific Intravitreal Injection Sales Quantity Market Share by Region (2019-2030)
Figure 57. Asia-Pacific Intravitreal Injection Consumption Value Market Share by Region (2019-2030)
Figure 58. China Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Japan Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Korea Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. India Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Southeast Asia Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Australia Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. South America Intravitreal Injection Sales Quantity Market Share by Type (2019-2030)
Figure 65. South America Intravitreal Injection Sales Quantity Market Share by Application (2019-2030)
Figure 66. South America Intravitreal Injection Sales Quantity Market Share by Country (2019-2030)
Figure 67. South America Intravitreal Injection Consumption Value Market Share by Country (2019-2030)
Figure 68. Brazil Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Argentina Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Middle East & Africa Intravitreal Injection Sales Quantity Market Share by Type (2019-2030)
Figure 71. Middle East & Africa Intravitreal Injection Sales Quantity Market Share by Application (2019-2030)
Figure 72. Middle East & Africa Intravitreal Injection Sales Quantity Market Share by Region (2019-2030)
Figure 73. Middle East & Africa Intravitreal Injection Consumption Value Market Share by Region (2019-2030)
Figure 74. Turkey Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Egypt Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Saudi Arabia Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. South Africa Intravitreal Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Intravitreal Injection Market Drivers
Figure 79. Intravitreal Injection Market Restraints
Figure 80. Intravitreal Injection Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Intravitreal Injection in 2023
Figure 83. Manufacturing Process Analysis of Intravitreal Injection
Figure 84. Intravitreal Injection Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
